Kiora Pharmaceuticals (KPRX) Accumulated Depreciation (2018 - 2021)
Kiora Pharmaceuticals' (KPRX) quarterly Accumulated Depreciation came in at $113132.0 in Q4 2021, up 21.68% YoY from $92974.0 in Q4 2020, and up 4.39% on a QoQ basis from $108378.0 in Q3 2021.
Kiora Pharmaceuticals (KPRX) Accumulated Depreciation (2018 - 2021) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 4 years of Accumulated Depreciation data on file, last reported at $113132.0 in Q4 2021.
- Quarterly Accumulated Depreciation rose 21.68% year-over-year to $113132.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $113132.0 (up 21.68% YoY) and the FY2021 annual result came in at $113132.0, up 21.68% from the prior year.
- Accumulated Depreciation improved to $113132.0 in Q4 2021, from $108378.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $113132.0 in Q4 2021 to a low of $56057.0 in Q4 2018.
- A 4-year average of $88115.8 and a median of $87128.0 in 2020 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2019 — Accumulated Depreciation soared 47.58% — and 2020, when it gained 12.38%.
- Tracing KPRX's Accumulated Depreciation over 4 years: stood at $56057.0 in 2018, then soared by 47.58% to $82729.0 in 2019, then increased by 12.38% to $92974.0 in 2020, then advanced by 21.68% to $113132.0 in 2021.
- The last three Accumulated Depreciation figures came in at $113132.0 (Q4 2021), $108378.0 (Q3 2021), and $103620.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kiora Pharmaceuticals | 15.64 Mn | 15.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 113,132.00 |
| Sep 30, 2021 | 108,378.00 |
| Jun 30, 2021 | 103,620.00 |
| Mar 31, 2021 | 97,244.00 |
| Dec 31, 2020 | 92,974.00 |
| Sep 30, 2020 | 88,322.00 |
| Jun 30, 2020 | 85,934.00 |
| Mar 31, 2020 | 83,546.00 |
| Dec 31, 2019 | 82,729.00 |
| Sep 30, 2019 | 76,061.00 |
| Jun 30, 2019 | 69,393.00 |
| Dec 31, 2018 | 56,057.00 |